Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Cefepime (DBL)

Cefepime (DBL) is a medicine containing the active ingredient(s) cefepime. On this page you will find out more about Cefepime (DBL), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: cefepime

Pack size information

Please select the pack size from the options directly below to view information on the medicine.

Information for medicine and pack size:
Cefepime (DBL) 1 g powder for injection, 1 vial

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Adults: DBL Cefepime Powder for injection is indicated in the treatment of the infections listed below when caused by susceptible bacteria: Lower respiratory tract infections, including pneumonia and bronchitis, Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections, Skin and skin structure infections, Intra-abdominal infections, including peritonitis and biliary tract infections, Gynaecological infections, Septicaemia, Empiric treatment in febrile neutropenic patients (See Precautions). DBL Cefepime Powder for injection is also indicated for surgical prophylaxis in patients undergoing intra-abdominal surgery. In this indication it is essential that metronidazole also be administered. Paediatrics: DBL Cefepime Powder for injection is indicated in paediatric patients over 2 months of age for the treatment of the infections listed below when caused be susceptible bacteria: Pneumonia, Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections, Skin and skin structure infections, Septicaemia, Empiric treatment in febrile neutropenic patients (See Precautions). Culture and susceptibility studies should be performed when appropriate to determine susceptibility of the causative organism(s) to cefepime. Empiric therapy with DBL Cefepime Powder for injection may be instituted before results of susceptibility studies are known; however, once these results become available, the antibiotic treatment should be adjusted accordingly. Because of its broad spectrum of bactericidal activity against gram-positive and gram-negative bacteria, DBL Cefepime Powder for injection can be used appropriately as monotherapy prior to identification of the causative organism(s). In the treatment of febrile neutropenia, consideration should be given to the need for other antibiotics in combination with DBL Cefepime Powder for injection. In patients who are at risk of mixed aerobic-anaerobic infection, including infections in which Bacterioides fragilis may be present, concurrent initial therapy with an anti-anaerobic agent is recommended before the causative organism(s) is known.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance White to pale yellow powder
Dosage Form Injection, powder for
Route of administration Intramuscular
Medicine schedule
Single Pack: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Vial
Storage temperature Store below 25 degrees Celsius
Storage conditions Protect from Light
Life time 24 Months
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback